Journal: Calcif Tissue Int 115, 260–268 (2024)
Authors: Sara Kretzschmar Haumann, Jesper Roed Sørensen, Jesper Hvass Schmidt. Lars Folkestad
License and source: This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
https://creativecommons.org/licenses/by/4.0/
Original publication available via PubMed
Summery: The following summary and key takeaways were prepared by the C4B team to support understanding of the scientific publication and are intended for informational purposes only. They do not replace the original article or professional medical advice.
This is a Danish, register-based cohort study following persons with OI and a reference population from the 1st of January 1995 until date of death, date of emigration from Denmark, or the end of follow-up on the 31st of December 2018.
Key Take Aways:
1. 17% of persons with OI are registered with some form of hearing loss and/or treated thereof at a much younger age than the general population.
2. The authors found an increase in incidence of hearing loss with 50% of the OI population, by the age of 75 sufering from hearing loss.
3. Regular follow-up may be needed in the OI population, but further research is needed to evaluate the risk of hearing
loss-related to genotype and clinical severity.